Global Anatomic Pathology Market Size, Share, Forecast Report, 2020-2027

The global Anatomic Pathology market garnered revenue around USD 33.2 Billion in 2020 and projected to reach USD 46.6 Billion in 2027, with at a compound annual growth rate of 7.5% throughout the estimate period from 2020 to 2027.

Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.

After commencing cancer surgeries or other surgeries, surgeons run through a series of pathology tests to decide the best treatment for patients. However, due to the lockdown in Q2 of many countries, elective and cancer surgeries have reduced significantly. For instance, according to the World Economic Forum, 28 million elective surgeries and 38% of global cancer surgeries have been delayed or postponed in Q2. As a result, the number of diagnostic tests has reduced. This has further reduced the sales of anatomic pathology products during the Q2 2020. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 tests.

Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Anatomic Pathology market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Anatomic Pathology market growth.

The global Anatomic Pathology market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

1. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHP Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Product & Service

• Services
• Histopathology
• Cytopathology
• Instruments
• Slide Staining Systems
• Tissue Processing Systems
• Cell Processors
• Microtomes
• Embedded Systems
• Coverslippers
• Other Instruments (Slide Labelers, Grossing Stations, and Paraffin Dispensers)
• Consumables
• Antibodies
• Primary Antibodies
• Secondary Antibodies
• Kits & Reagents
• Stains & Solvents
• Fixatives
• Other Kits & Reagents (Blocking Sera, Chromogenic Substrates, Stabilizers, and Diluents)
• Probes
• Other Consumables (Microtome Blades, Slides, Coverslips, and Cassettes)

By Application

• Disease Diagnosis
• Cancer
• Breast Cancer
• Lung Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Other Cancers (Includes Cancers of the Bone, Thyroid, Cervix, Skin, Lymphoma, Gallbladder Carcinoma, Renal Cell Carcinoma, and Pleomorphic Sarcoma)
• Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
• Medical Research

By End-User

• Hospital Laboratories
• Clinical Laboratories
• Other End Users

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA